Skip to main content
Arshad Khanani, MD, Ophthalmology, Reno, NV, Renown Regional Medical Center

ArshadMohammadKhananiMD

Ophthalmology Reno, NV

Retinal Disease

Physician

Dr. Khanani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Khanani's full profile

Already have an account?

Education & Training

  • Texas Tech University Health Sciences Center at Lubbock
    Texas Tech University Health Sciences Center at LubbockResidency, Ophthalmology, 2005 - 2008
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 2004 - 2005
  • Texas Tech University Health Sciences Center at Lubbock
    Texas Tech University Health Sciences Center at LubbockClass of 2004

Certifications & Licensure

  • NV State Medical License
    NV State Medical License 2010 - 2023
  • TX State Medical License
    TX State Medical License 2007 - 2012
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration  
    Arshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology

Authored Content

  • Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
  • Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
  • Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020

Press Mentions

  • LADDER Demonstrates Efficacy of Port Delivery System with Ranibizumab
    LADDER Demonstrates Efficacy of Port Delivery System with RanibizumabJuly 30th, 2019
  • AAO 2018: New STAIRWAY Study Data Shows Potential for Extended Durability with Faricimab in nAMD
    AAO 2018: New STAIRWAY Study Data Shows Potential for Extended Durability with Faricimab in nAMDNovember 12th, 2018
  • A Look at 3-D Eye Surgery
    A Look at 3-D Eye SurgeryJuly 26th, 2016
  • Join now to see all

Professional Memberships

Hospital Affiliations